Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

22 mai 2024 06h55 HE | Source: ANTION BIOSCIENCES SA

Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoimmune disease

Aiming for a best-in-class solution to treat and cure B-cell driven autoimmune diseases
06 mars 2024 06h55 HE | Source: ANTION BIOSCIENCES SA

Antion Biosciences announces latest data and validation of its technology platform through important milestone achievements

Antion Biosciences release in vivo proof-of-concept data for miCAR7 and milestone achievement for Allogene Therapeutics
17 oct. 2023 06h55 HE | Source: ANTION BIOSCIENCES SA

Antion Biosciences Announces Presentation of Two Abstracts from its Multiplex Cell Engineering Platform at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting

Functional demonstration of Antion’s uniquely capable technology to develop allogeneic anti-CD19 CAR T-cells with “tuned” silencing of HLA-I Latest advancements in the application of Antion’s miCAR...